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inhibition of indole production 
increases the activity of quinolone 
antibiotics against E. coli persisters
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Persisters are a sub‑population of genetically sensitive bacteria that survive antibiotic treatment by 
entering a dormant state. The emergence of persisters from dormancy after antibiotic withdrawal 
leads to recurrent infection. Indole is an aromatic molecule with diverse signalling roles, including a 
role in persister formation. Here we demonstrate that indole stimulates the formation of Escherichia 
coli persisters against quinolone antibiotics which target the GyrA subunit of DNA gyrase. However, 
indole has no effect on the formation of E. coli persisters against an aminocoumarin, novobiocin, 
which targets the GyrB subunit of DNA gyrase. Two modes of indole signalling have been described: 
persistent and pulse. The latter refers to the brief but intense elevation of intracellular indole during 
stationary phase entry. We show that the stimulation of quinolone persisters is due to indole pulse, 
rather than persistent, signalling. In silico docking of indole on DNA gyrase predicts that indole 
docks perfectly to the ATP binding site of the GyrB subunit. We propose that the inhibition of indole 
production offers a potential route to enhance the activity of quinolones against E. coli persisters.
The decreasing effectiveness of antibiotic therapy represents an unprecedented, worldwide threat to human and 
animal health. The most widely publicised, and best understood, aspect of this problem is antibiotic resistance. 
This involves genetic change, through mutation or horizontal gene transfer. The target organism is rendered 
immune to the antibiotic by inactivation of the drug, alteration of its target or export from the  cell1. A less well 
studied but increasingly important aspect of the anti-bacterial problem is the ability of small sub-populations 
(< 1%) of genetically sensitive bacteria to survive high concentrations of antibiotic by entering a dormant or 
partially-dormant state. These cells are known as antibiotic  persisters2–4. When treated with a bactericidal con-
centration of an antibiotic, persisters display a temporary, non-heritable phenotype where they survive but do 
not replicate. When the antibiotic therapy is withdrawn, persisters revert to the growing state, giving rise to a 
population characterised by the same antibiotic sensitivity as the original population. In contrast, resistant cells 
continue to grow and divide in the presence of the antibiotic and the resistance phenotype is  heritable5–7.
The mechanisms by which persister cells enter a dormant state are not well understood. It has been sug-
gested that the activation of chromosome-encoded toxin-antitoxin systems is an important  mechanism8 although 
this has recently been  questioned9. Links have also been made to the stringent response and carbon source 
 transitions10. A few  reports11,12 have suggested a role for the signalling molecule indole and this seems plausible 
because indole has been known for several years to induce reversible E. coli  dormancy13.
Indole is an aromatic signalling molecule produced by over 85 species of bacteria encompassing Gram-
negatives, Gram-positives, pathogens and non-pathogens14. It is produced from tryptophan by the enzyme 
tryptophanase (TnaA)15. There exist two modes of indole action: persistent or pulse. In persistent signalling, 
indole is present in the culture for an extended period at a relatively low concentration (< 1 mM). In pulse 
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signalling, intra-cellular indole reaches a high concentration (50 mM) for a short period (10–20 min) during 
stationary phase  entry16,17.
In this study we examine the role of indole in the formation of persisters against antibiotics that target DNA 
gyrase, a bacterial type II topoisomerase. DNA gyrase is comprised of two subunits, gyrase A (GyrA) and gyrase 
B (GyrB), which form an  A2B2 complex in the active  enzyme18. The supercoiling activity of DNA gyrase involves 
the breakage and reunion of both polynucleotide strands, mediated by the GyrA  subunits19. The GyrB subunits 
are responsible for the ATPase activity required for  supercoiling20. One class of gyrase inhibitors, quinolone 
antibiotics, targets the GyrA subunit, stabilising double-strand breaks in the  DNA21,22. A second class of inhibi-
tors, aminocoumarins, targets the GyrB subunit and inhibits enzyme activity without stabilising double-strand 
 breaks20.
It has been known for some time that the indole concentration reached during pulse signalling is sufficient 
to inhibit supercoiling by DNA gyrase in vitro23. Interestingly, the inhibition of DNA gyrase by indole occurs 
without the accumulation of double-strand breaks, thereby mimicking aminocoumarin antibiotics and suggesting 
a potential interaction between indole and the GyrB  subunit19. Consistent with this, it was proposed from an in 
silico analysis that a derivative of indolinone, an indole analogue, may bind to the GyrB subunit of DNA  gyrase24.
In the present study, we compared the proportion of persisters in wild-type and indole-negative (ΔtnaA; 
tryptophanase knockout) cultures of E. coli BW25113 after treatment with a range of antibiotics that target DNA 
gyrase. The absence of indole production decreased the number of persisters surviving quinolone treatment, with 
ciprofloxacin showing the most pronounced effect. Restoration of the wild-type level of ciprofloxacin persist-
ers was achieved by an experimentally-applied indole pulse but not by supplementation with the lower indole 
concentrations associated with persistent signalling. In silico docking of indole on DNA gyrase predicts that 
indole docks at the ATP binding site of GyrB, suggesting that indole prevents the stabilisation of double-strand 
breaks and induces cellular quiescence by inhibiting gyrase activity.
Results
Indole stimulates the formation of E. coli persisters against quinolone antibiotics. The fre-
quency of persisters in wild-type and indole-negative (ΔtnaA) cultures of E. coli BW25113 was monitored after 
treatment with four quinolone antibiotics. One antibiotic was chosen from each of the four generations of qui-
nolones: nalidixic acid (1st generation), ciprofloxacin (2nd generation), levofloxacin (3rd generation) and moxi-
floxacin (4th generation)25,26. The minimum inhibitory concentration (MIC) of each antibiotic was determined 
for both wild-type and ΔtnaA strains (Supplementary Information; Table S1). Antibiotics at 100 × MIC (suf-
ficient to distinguish persistence from transient modes of  resistance5) were added to exponentially growing E. 
coli cells for up to five hours and killing curves were generated. In each case there was a greater proportion of 
persisters in the wild-type cultures than the indole non-producing mutant. For nalidixic acid, levofloxacin and 
moxifloxacin the effect was relatively small (wild-type: ΔtnaA survival ratio approx. 2–4) with a bigger difference 
(approx. tenfold) effect for ciprofloxacin (Fig. 1). The result implies that in wild-type culture, 90% of ciprofloxa-
cin persisters are indole-dependent. However, the fact that the indole-negative strain still produced persisters, 
confirms the existence of additional, indole-independent persistence mechanisms.
Pulse signalling generates indole‑dependent quinolone persisters in E. coli. If indole produc-
tion stimulates the formation of persisters against quinolone antibiotics, it might be possible to restore the wild-
type persister frequency in an indole-negative strain by adding indole to the culture. Indole exerts its effect 
through one of two signalling modes, persistent or pulse, and the effect of each of these was explored on an 
indole-negative strain.
Persistent signalling occurs at indole concentrations found in stationary phase cultures. In LB cultures, where 
most indole is synthesised during stationary phase entry, this is in the range 0.3–0.7 mM10,17,27–29. To mimic 
this, LB cultures of the indole non-producing strain BW25113 ∆tnaA were supplemented with 0.5 mM indole. 
100 × MIC of each of the four quinolone antibiotics was added and killing curves were generated over five hours 
of treatment. The killing curves for the ∆tnaA, with or without 0.5 mM indole, are not significantly different. 
The error bars of the curves for these two conditions clearly overlap (Fig. 2).
The effect of indole pulse signalling on the frequency of quinolone persisters was investigated by applying an 
artificial indole pulse. For wild-type cells growing in LB, the concentration of cell-associated indole during the 
pulse is around 60  mM11. An artificial indole pulse can be achieved by adding of 4–5 mM indole to the culture 
 supernatant16,17 (Indole has a greater affinity for cells compared to the aqueous culture medium, which explains 
the difference in concentration between the cell-associated and the culture  medium16,17). We treated exponentially 
growing cultures  (OD600 = 0.15) of BW25113 ∆tnaA in LB with 5 mM indole for 20 min. The indole was removed 
by washing the cells in PBS before resuspending in fresh LB. 100 × MIC of each antibiotic was added and killing 
curves were generated over the next five hours (Fig. 2). Comparing ∆tnaA with and without the 5 mM pulse of 
indole, there was a significant difference, with no overlap of the error bars. The same result was obtained for all 
four antibiotics (Fig. 2). Another striking effect of the pulse was a reduction of the rate of cell death over the first 
three hours of antibiotic treatment; a phenomenon known as antibiotic  tolerance5.
The ionophore action of indole during the pulse is not responsible for the formation of qui‑
nolone persisters in E. coli. At concentrations reached during pulse signalling, indole acts as a proton 
 ionophore13,16,29,30. If membrane permeabilisation by indole is important for the formation of quinolone per-
sisters, it should be possible to increase the frequency of persisters in an indole-negative strain by pulsing with 
an alternative ionophore. We therefore treated cultures of BW25113 ∆tnaA, growing exponentially in LB, with 
100 µM carbonyl cyanide m-chlorophenyl hydrazone (CCCP) or 800 µM 2,4-Dinitrophenol (DNP) for 20 min. 
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These chosen concentrations of CCCP and DNP have been previously shown to produces the same outcome as 
an artificial indole  pulse30. The ionophore was then removed by washing the cells in PBS before resuspending in 
fresh LB. 100 × MIC of ciprofloxacin was added and killing curves were generated over five hours. Neither of the 
ionophores resulted in a significant increase in the frequency of persisters for the ∆tnaA mutant strain (Fig. 3a). 
Thus, we conclude that the ionophore action of indole is not sufficient for the formation of quinolone persisters 
in E. coli.
indole does not enhance E. coli persisters against an aminocoumarin antibiotic. We have 
shown that indole enhances the formation of quinolone persisters in E. coli. The active form of DNA gyrase 
is an  A2B2  complex18 in which quinolones target the GyrA  subunit20–22. In contrast, aminocoumarins, such as 
novobiocin, target the GyrB subunit of the  enzyme20. To investigate whether indole also enhances formation of 
novobiocin persisters, 100 × MIC of the antibiotic was added to cultures of wild-type E. coli and ∆tnaA growing 
exponentially in LB and the killing curves were generated over five hours of treatment. Additionally, the effect of 
exogenous indole upon indole-negative cells was tested either by supplementing a culture with 0.5 mM indole 
or by applying a pulse of 5 mM indole for 20 min, following the procedures described earlier. Interestingly, there 
was no significant difference in the number of persisters after novobiocin treatment of wild-type and ∆tnaA 
strains. Moreover, neither indole supplementation (0.5 mM) nor an experimentally-applied pulse caused a sig-
nificant change in the number of persisters with the ∆tnaA strain (Fig. 3b).
Tryptophanase expression and indole production are not elevated in response to treatment 
with ciprofloxacin. We tested whether indole production is increased in response to ciprofloxacin treat-
ment. Increasing indole could be achieved either by increasing tryptophanase expression or by stimulating 
indole production by tryptophanase already present. We used an E. coli strain which expresses GFP-tagged tryp-
Figure 1.  Indole enhances the formation of quinolone persisters in E. coli. Percentage of survival of 
exponential-phase  (OD600 = 0.15) wild-type (indole positive) and ΔtnaA (indole negative) strains of BW25113 
E. coli in LB medium treated for five hours with 100 × MIC (a) nalidixic acid, (b) ciprofloxacin, (c) levofloxacin 
and (d) moxifloxacin. The average ratio of survival (wild-type/ΔtnaA) in the plateau (3 to 5 h after antibiotic 




Scientific RepoRtS |        (2020) 10:11742  | https://doi.org/10.1038/s41598-020-68693-w
www.nature.com/scientificreports/
tophanase from its native  promoter29 to explore the effect of the antibiotic on enzyme expression. Ciprofloxacin 
(100 × MIC) was added to a culture growing exponentially and samples were taken over the next hour and 
analysed by flow cytometry. Both the mean fluorescence and the distribution of fluorescence among individual 
cells were similar to an untreated sample (Fig. 4a), indicating that ciprofloxacin treatment had no effect on the 
amount of tryptophanase in the cells.
Next, we investigated whether ciprofloxacin affects indole production. Indole concentrations are low 
(20–40 µM) in exponential phase cultures so a C18 solid phase extraction column was used as a pre-concentration 
step before performing the Kovacs  assay30. Ciprofloxacin (100 × MIC) was added to an exponentially growing 
culture of wild-type E. coli and samples were taken over five hours of treatment for the measurement of super-
natant indole. The concentration of indole in the supernatant before antibiotic addition was around 25 µM and 
showed little change during the treatment (Fig. 4b).
Indole interacts with the GyrB subunits of DNA gyrase. Indole at 4–5 mM, when added to a bacte-
rial culture, generates an intracellular concentration equivalent to that detected during pulse signalling. The 
same concentration inhibits DNA gyrase supercoiling activity in  vitro without introducing double-strand 
 breaks19,23. The indole moiety of an indolinone derivative has been shown to bind in the ATP-binding pocket of 
 GyrB24, suggesting that indole might inhibit the ATPase activity of DNA gyrase. Gyrase inhibition, promoting 
dormancy without inducing DNA double-strand breaks, offers a plausible mechanism for the higher frequency 
of quinolone persisters seen in indole-producing bacteria and in non-producing strains subjected to an experi-
menter-applied indole pulse.
To investigate this potential indole-gyrase interaction, a preliminary docking exercise was performed using 
VIDA software (OpenEye Scientific Software) with the refined composite structure, P24, that was generated by 
Oblak and colleagues to dock indoline  derivatives24. The modelling showed indole docking at the core of the 
ATP-binding site of GyrB. Following the preliminary exercise, docking in Autodock Vina was performed with 
structures with protein data bank (PDB) numbers 1EI1, 4WUD, and 4PRV to provide a strong consensus pose 
(Fig. 5a–c). 1EI1 and 4WUD gave docking within an RMSD of 0.7 Å of the consensus pose in more than 95% of 
repeats. Docking to 4PRV was less reproducible, however the most common docking site was consistent with the 
other structures (46% within an RMSD of 0.8 Å). 4PU9, which gave a consistent pose (98% within an RMSD of 
1.5 Å), deviated from the others by a RMSD of 1.38 Å. Docking in LeDock supported the Vina consensus, with 
all structures yielding a result within a RMSD of 1 Å of the Vina consensus pose, with LeDock scoring an average 
of − 3.14 kcal mol−1 and the Vina consensus pose scoring − 5.8 kcal mol−1. The consensus pose corresponds well 
to indolinone derivatives docked previously, and is situated between the residues implicated in their binding by 
structural  NMR24 (Fig. 5d,e). Further, the pose aligns the indole nitrogen responsible for hydrogen bonding to 
residue D73 with a nitrogen on adenine of ADPNP when bound to DNA gyrase subunit B, which also forms a 
hydrogen bond to D73 (Fig. 5f).
Figure 2.  Indole pulse signalling stimulates quinolone persister formation in E. coli. Percentage of survival of 
exponential-phase  (OD600 = 0.15) BW25113 ΔtnaA E. coli in LB medium treated for five hours with 100 × MIC 
(a) nalidixic acid, (b) ciprofloxacin, (c) levofloxacin and (d) moxifloxacin. For indole supplementation, 0.5 mM 
indole was added to ΔtnaA cultures prior to antibiotic addition. For the indole pulse, ΔtnaA cultures were 
treated for 20 min with 5 mM indole then washed and resuspended in fresh LB prior to antibiotic addition. 
All data are the means ± SD of a minimum of three biological replicates. Data for the percentage of survival of 
BW25113 wild-type and ∆tnaA in LB presented in Fig. 1 are included for comparison.
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Discussion
Our experiments demonstrate the existence of an indole-dependent mechanism for the formation of E. coli 
persisters that survive high-dose quinolone treatment. The indole-dependent effect is most pronounced for 
ciprofloxacin where persisters are reduced ten-fold in an indole-negative strain (Fig. 1).
The effect of indole on the formation of ciprofloxacin persisters seems to be entirely dependent upon the 
pulse signalling mode. Supplementation of the growth medium of an indole-negative (tryptophanase knock-out) 
culture with 0.5 mM indole (representative of indole in LB stationary phase culture) failed to restore the wild-
type level of persisters (Fig. 2). However, an externally-applied indole pulse restored the number of ciprofloxacin 
persisters to the wild-type value (Fig. 2). Interestingly, the external pulse also increased persisters and reduced 
the rate of killing by nalidixic acid, levofloxacin and moxifloxacin.
We asked whether ciprofloxacin itself triggers the indole pulse that enhances persister formation. However, 
we found that neither the level of the indole-producing enzyme tryptophanase, nor the concentration of indole 
in the culture supernatant, was altered by ciprofloxacin (Fig. 4). In the absence of antibiotics, an indole pulse 
occurs during the transition of an LB culture of E. coli from exponential to stationary phase and it seems likely 
that this is responsible for creating persisters cells that survive ciprofloxacin treatment during subsequent expo-
nential growth. Thus, although the pulse of indole is transient, its effect appears to be long-lasting; a paradox 
that we return to later in this discussion.
At concentrations similar to those seen during pulse signalling, indole functions as a proton  ionophore13,16,29,30. 
However, our experiments suggest that membrane permeabilisation is not the mechanism of ciprofloxacin per-
sister formation, since an externally-applied pulse of a non-biological ionophore (CCCP or DNP) did not produce 
the same outcome as an indole pulse (Fig. 3a). We therefore explored an alternative possibility that persisters 
might arise from indole inhibition of DNA gyrase.
The DNA supercoiling reaction of DNA gyrase involves the binding of a strand of DNA, the G (or gate) 
segment, at the interface of GyrA and  GyrB32. A section of DNA then wraps around DNA gyrase, bringing a 
second segment, the T (or transported) segment, into the gate and positioning it above the G  segment33. DNA 
gyrase then cleaves the G segment, forming a covalent bond between DNA and an active tyrosine residue in 
Figure 3.  The frequency of E. coli persisters is not affected by (a) non-biological ionophores (CCCP and 
DNP) before ciprofloxacin treatment or (b) indole before novobiocin treatment. (a) Percentage survival of 
exponential-phase  (OD600 = 0.15) BW25113 ∆tnaA E. coli in LB medium treated for 20 min with 100 µM 
CCCP or 800 µM DNP, then washed and resuspended in fresh LB and treated for five hours with 100 × MIC 
ciprofloxacin. Data for the percentage survival of BW25113 wild-type and ∆tnaA, with and without an indole 
pulse (Figs. 1 and 2), are included for comparison. All data are the mean ± SD of a minimum of three biological 
replicates. (b) Percentage survival of exponential-phase  (OD600 = 0.15) wild-type (indole-positive) and ΔtnaA 
(indole-negative) strains of BW25113 E. coli in LB medium treated for five hours with 100 × MIC novobiocin. 
For indole supplementation, prior to antibiotic addition, ΔtnaA cultures were supplemented with 0.5 mM 
indole. To mimic an indole pulse prior to antibiotic addition, ΔtnaA cultures were treated for 20 min with 5 mM 
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the enzyme. Upon binding of ATP, the T segment is passed through the broken G  segment34,35. ATP hydrolysis 
and the release of ADP resets the DNA gate for another T segment to be  captured35. This mechanism presents a 
number of opportunities for inhibition by antibacterial drugs and, potentially, indole. The transient, covalently-
linked enzyme and DNA may be stabilised, or ATP binding or hydrolysis may be targeted to prevent the closure 
of the gate and thus the loss of T segment capture. Quinolones and aminocoumarins are classes of drugs that 
take advantage of these two mechanisms,  respectively20–22.
Indole inhibits DNA gyrase supercoiling activity without the accumulation of double-strand breaks. This 
is similar to the effect of aminocoumarins, such as  novobiocin23, that target GyrB ATPase by blocking access 
to the ATP-binding  site36. In addition, an in silico study by Oblak and colleagues proposed that a derivative of 
indolinone, an indole analogue, binds to the GyrB subunit of DNA  gyrase24. Building upon this indirect evi-
dence, our in silico docking exercise provided a strong indication that indole docks at the ATP-binding pocket 
of GyrB (Fig. 5). If indole binding to GyrB inhibits gyrase activity by a mechanism similar to aminocoumarins 
(i.e. through inducing the closure of the GyrB gate, preventing T segment capture) then indole might be expected 
to provide protection against quinolones. This is because T segment capture is a prerequisite for cleavage of the 
G segment and subsequent formation of a covalent bond with a tyrosine residue at the interface of GyrA and 
GyrB. It is this bond that is irreversibly stabilised by quinolones, thus preventing DNA release. At the same 
time, reduced DNA gyrase activity would inhibit DNA replication and transcription, inducing dormancy and 
promoting the formation of persister cells. In support of this hypothesis, we note that, indole has no effect on 
novobiocin persister formation (Fig. 3b), as would be expected if indole and novobiocin compete the same bind-
ing site. It is plausible that indole is acting as a competitive inhibitor of ATP binding, thus preventing T segment 
capture, or preventing release of G segment through lack of a hydrolysable bond to provide energy to progress 
the mechanism. One could argue that indole might function similarly to the non-hydrolysable analogue of ATP, 
ADPNP, in that it may close the DNA gate and prevent DNA  capture34,35.
Although DNA gyrase inhibition appears to be a plausible mechanism of indole-mediated persister gen-
eration, it remains to be explained how persisters formed by a pulse of indole during stationary phase entry 
can still exist in exponential phase many hours after the pulse. One possibility is that during the pulse the 
transient cell-associated indole concentration is sufficiently high to cause a local re-folding of GyrB that ren-
ders the topoisomerase inactive. In support of this, it has been reported that GyrB is structurally unique, with 
an unconventional  fold37, and its misfolding reduces DNA gyrase  activity38. The cell would be rendered dor-
mant and immune to ciprofloxacin until the defective gyrase was either refolded (e.g. via chaperone action) or 
Figure 4.  The expression of tryptophanase and the production of indole in E. coli are not affected by 
ciprofloxacin treatment. (a) Single cell distributions of tryptophanase-GFP. Exponential-phase samples 
 (OD600 = 0.15) from LB cultures of E. coli BW25113 (negative control) and BW25113 TnaA-GFP were analysed 
by flow cytometry (100,000 events per sample). The fluorescence distributions of GFP in the TnaA-GFP 
culture is shown before (positive control) and after (10, 20, 30, 40, 50 and 60 min) the addition of ciprofloxacin 
(100 × MIC). In agreement with a previous  study31, all samples showed 3 distinct peaks implying sub-
populations of cells with low, medium and high tryptophanase content (peaks indicated by black, blue and green 
vertical lines, respectively). (b) Indole concentration (µM) in the supernatant of exponential-phase samples 
 (OD600 = 0.15) from LB cultures of E. coli BW25113 wild-type before (time zero) and after (1, 2, 3, 4 and 5 h) 
treatment with ciprofloxacin (100 × MIC). Indole was measured by the Kovacs assay after passing each sample 
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resynthesised. Given that indole derivatives such as compound 1 and indoline bind with affinities of 10 µM and 
10 mM,  respectively24,39, perhaps indole may bind with a similar affinity to the latter.
The structural differences between quinolones also present an interesting line of enquiry. The results of this 
study have shown that four quinolones generate persisters via an indole-dependent mechanism. However, the 
largest difference in the number of persisters between the indole producing and non-producing strains was seen 
with ciprofloxacin and, to a lesser degree, moxifloxacin (Fig. 1). This may be due to a major structural modifica-
tion in both ciprofloxacin and moxifloxacin that is absent from nalidixic acid and levofloxacin, a cyclopropyl 
group at position 1 that is part of the enzyme–DNA binding complex and considered the most effective modi-
fication to this  site40. Interestingly, a hydrogen or fused ring at position 8 has also been reported to potentiate 
quinolone targeting towards topisomerase IV, and moxifloxacin has a methoxy group at this position, which 
might increase targeting to DNA  gyrase40.
In conclusion, our work has demonstrated the existence of an indole-dependent mechanism for the formation 
of quinolone persisters that is particularly effective for the fluoroquinolone ciprofloxacin. Evidence presented 
here suggests it involves the inhibition of DNA gyrase by high concentrations of indole that are seen during 
stationary phase entry. It is important to note that some persisters are seen, even in an indole-deficient (ΔtnaA) 
strain, which suggests that there is also an indole-independent mechanism of persister formation in operation. 
Nevertheless, the data suggest that the investigation of indole inhibitors as a method to reduce indole-dependent 
persisters in E. coli could have a major clinical relevance, for example in the treatment of urinary tract infections 
(UTIs) caused by uropathogenic E. coli. The effectiveness of indole inhibition in reducing E. coli persisters in 
UTIs could potentially be tested in vivo in the mouse  model41 and could be particularly relevant in cases where 
E. coli persisters are linked to the relapse of infections following the withdrawal of treatment.
Experimental procedures
Chemicals and antibiotics. All chemicals and antibiotics were purchased from Sigma, except MIC Etests 
which were purchased from bioMérieux. Antibiotics were prepared as stock solutions in water, filter-sterilised, 
and stored as 1.5 mL aliquots at − 20 °C. A 1 × phosphate buffered saline (PBS) solution was used in all washing 
steps. Indole stock solutions (500 mM) were prepared in absolute ethanol and an ethanol control was included 
in all assays were the indole stock was used.
Figure 5.  Molecular docking of indole in DNA gyrase predicts that indole docks at the ATP-binding pocket 
of GyrB. (a) The consensus docking of indole with DNA-gyrase B shown within structure 1EI1. (b) The 
consensus docked positioned of indole within 1EI1 (orange) and the consensus docked position of indole 
within 4PU9 (purple). (c) A 2D interaction diagram of the consensus pose in the binding pocket. (d) The 
consensus docked position of indole to DNA gyrase B within 1EI1, with residues identified by  NMR24 shown 
in stick representation. (e) The consensus position of indole docked to DNA gyrase B shown within 1EI1, 
with key residues for the docked pose shown in stick representation. (f) The consensus docked positioned of 
indole within 1EI1 (orange), with aspartic acid D73 depicted in stick form. ATP analogue ADPNP (green) is 
shown in the 1EI1 structure. The close alignment between the indole and ADPNP nitrogen atoms responsible 
for hydrogen bonding to D73 is clearly visible. (a–f) were generated using PyMOL 2.2.2 (URL https ://pymol 
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Strains and culture conditions. All experiments were performed using E. coli K12 BW25113 wild-type, 
a corresponding kanamycin resistant tryptophanase knockout and a derivative expressing TnaA-GFP from its 
native promoter (Supplementary Information; Table S2). Luria–Bertani (LB) medium was used for all experi-
ments (Supplementary Information; Table S3) and kanamycin (50 µg ml−1) was added for ΔtnaA cultures. Cells 
were cultured routinely at 37  °C, with shaking at 120  rpm, in LB medium. Cultures were streaked to single 
colonies on LB agar plates and incubated overnight at 37 °C to generate stock plates. An independent colony was 
picked from the stock plate to inoculate LB broth and incubated overnight at 37 °C in the shaking incubator. 
Overnight cultures were diluted to  OD600 = 0.01 in a fresh LB and allowed to grow to  OD600 = 0.15 before being 
used for subsequent assays.
Indole supplementation and indole, CCCP and DNP pulse-mimic were performed as described  previously30. 
Briefly, for indole supplementation assays, indole (dissolved in ethanol) was added to a final concentration of 
0.5 mM to a culture of BW25113 ΔtnaA. Ethanol alone was added to controls where appropriate. To impose an 
artificial pulse signal, indole (5 mM), CCCP (100 µM) or DNP (800 µM) (all dissolved in ethanol) was added to 
BW25113 ΔtnaA at  OD600 = 0.15; ethanol alone was added to controls where appropriate. Cells were incubated for 
20 min at 37 °C in the shaking incubator and then harvested by centrifugation at 2755 g for 10 min (Eppendorf 
5,810 R centrifuge). The supernatant was removed, and the cells were resuspended in an equal volume of 1 × PBS 
(pH 7.0). Traces of Indole, CCCP or DNP were removed by centrifugation and removal of the supernatant. Cells 
were resuspended in an equal volume of fresh LB before being used for subsequent assays.
Persister assays (100 × MIC antibiotic challenge). A time zero sample was taken when cultures 
reached an  OD600 of 0.15, immediately before the antibiotic (100 × MIC) was added. The flask was placed in a 
37 °C shaking incubator for five hours and samples were taken after 1, 3, and 5 h of treatment and centrifuged 
for 7 min at 3,050 g at room temperature. After discarding the supernatant, the cell pellet was washed with an 
equal volume of 1 × PBS buffer to remove residual antibiotic and the pellet finally resuspended in an appropriate 
volume of PBS buffer. Washed samples were immediately serially diluted in 1 × PBS and 100 μl of two or more 
appropriate dilutions were spread on LB agar plates. This was carried out to limit the time bacteria were kept 
in the non-growing conditions after the antibiotic treatment. The plates were incubated in a static incubator at 
37 °C and examined after 24 h to determine the cfu (colony forming units). The percentage survival was calcu-
lated by comparing the cfu of samples after 1, 3 and 5 h of treatment to the cfu at time zero.
Flow cytometry. Samples were taken at  OD600 = 0.15 before and after ciprofloxacin treatment. All samples 
were kept on ice for few seconds then analysed directly in a CyAn ADP (Beckman Coulter, Brea, CA, USA). 
GFP fluorescence was excited at 488  nm and measured through an emission filter of 530 ± 20  nm. For each 
sample, 100,000 events were collected at a rate between 2000 and 5,000 events per second. Data were collected 
using Summit 4.3 Software and analysed using R 1.0.13642 with the following packages: flowCore (data analysis), 
flowViz (plotting) and flowDensity (automated gating).
Indole measurement by C18/Kovacs assays. Samples were taken at  OD600 = 0.15 before and after cip-
rofloxacin treatment and centrifuged at 4 °C for 10 min at 3,050 g. The supernatant was removed, and the cell 
pellet was discarded. Indole concentration in the supernatant was measured using the C18/Kovacs method as 
previously  described30.
Briefly, C18 solid phase extraction (SPE) cartridges (SampliQ C18, Agilent, CA, USA) were used to con-
centrate indole ten-fold before performing the Kovacs assay. Each cartridge (500 mg octadecylsilane – 6 ml) 
was equilibrated by flowing-through 10 ml 1-pentanol, followed by 10 ml deionised water. Each sample (50 ml 
culture supernatant) was flowed through an equilibrated cartridge and the cartridge was then washed with 10 ml 
deionised water. Indole was eluted from the cartridge with 5 ml 1-pentanol. 100 µl of × 10 indole concentrated 
samples (in 1-pentanol) were incubated with 150 µl of Kovacs reagent (10 g of p-dimethylamino-benzaldehyde 
dissolved in a mixture of 50 ml of HCl and 150 ml of amyl alcohol) for 5 min at room temperature. The reaction 
produced a soluble red product, which was measured spectrophotometrically at 530 nm (SpectraMax 190 Micro-
plate reader; Molecular Devices, CA, USA). Eight known indole concentrations from 0 to 600 µM (in 1-pentanol) 
were assayed in triplicate and the mean results were used to construct a standard curve. Indole concentrations 
in unknown samples (also tested in triplicate) were calculated by comparison.
In silico docking of indole in DNA gyrase. Indole was docked to DNA gyrase subunit B structures with 
the following PDB codes: 1EI1, 4PRV, 4PRX, 4PU9, and 4WUD with 100 replicates in Autodock  Vina43. Further 
docking to the binding site identified in Autodock Vina was conducted in  LeDock44, using the same structures. 
 PyMOL45 was used for structure alignment, visualisation and figure generation,  PoseView46 was used for 2D 
interaction diagram generation.
Data availability
The data that support the findings of this study is available in Apollo (University of Cambridge Repository) at 
https ://doi.org/10.17863 /CAM.46130 .
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